ARS Pharmaceuticals, Inc. ( SPRY) - Stock Earnings
SPRY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -41.3 million USD | 28.1 million USD |
| 2026Q1 | -60.6 million USD | 22.7 million USD |
| 2026Q2 | -62.3 million USD | 33.7 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
SPRY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -54.4 million USD | 30000 USD |
| 2024 | 8.0 million USD | 89.1 million USD |
| 2025 | -171.3 million USD | 84.3 million USD |
| 2026 Est. | — | — |
SPRY
Price: $5.50
52 week price:
Earnings Per Share: -2.18 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 634.5 million